Protein measurement
|
group |
|
Laboratory Procedure
|
75
|
422
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Protein C measurement
|
phenotype |
|
Laboratory Procedure
|
62
|
522
|
0.100 |
None |
1.000 |
2 |
3
|
2010 |
2017 |
Protein C antigen measurement
|
phenotype |
|
Laboratory Procedure
|
62
|
522
|
0.100 |
None |
1.000 |
2 |
3
|
2010 |
2017 |
Polycystic Ovary Syndrome
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
988
|
363
|
0.010 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Platelet Count measurement
|
phenotype |
|
Laboratory Procedure
|
265
|
457
|
0.100 |
None |
1.000 |
3 |
1
|
2011 |
2018 |
Phospholipid measurement
|
phenotype |
|
Laboratory Procedure
|
58
|
306
|
0.100 |
None |
1.000 |
2 |
3
|
2011 |
2013 |
Pediatric Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
191
|
67
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Pancreatic carcinoma
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
2689
|
322
|
0.010 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Overweight and obesity
|
disease |
|
Disease or Syndrome
|
81
|
29
|
0.010 |
None |
1.000 |
1 |
2
|
2011 |
2011 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
0.090 |
None |
1.000 |
9 |
2
|
2003 |
2018 |
Non-alcoholic Fatty Liver Disease
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1058
|
222
|
0.200 |
None |
1.000 |
21 |
2
|
2011 |
2020 |
Neutrophil count (procedure)
|
phenotype |
|
Laboratory Procedure
|
145
|
234
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Neural Tube Defects
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Congenital Abnormality
|
304
|
122
|
0.010 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Myocardial Ischemia
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
756
|
103
|
0.010 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Myocardial Infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
1800
|
680
|
0.010 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Monogenic diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
30
|
19
|
0.010 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Metabolic Syndrome X
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1125
|
591
|
0.200 |
None |
1.000 |
14 |
6
|
2008 |
2020 |
Metabolic Diseases
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
945
|
50
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Maturity onset diabetes mellitus in young
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
105
|
49
|
0.020 |
None |
1.000 |
2 |
|
1994 |
2008 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Malignant neoplasm of stomach stage IV
|
disease |
|
Neoplastic Process
|
78
|
7
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Malignant neoplasm of pancreas
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
2667
|
277
|
0.010 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Lymphocyte Count measurement
|
phenotype |
|
Laboratory Procedure
|
338
|
456
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
6 |
4
|
2008 |
2019 |
Liver diseases
|
group |
Digestive System Diseases
|
Disease or Syndrome
|
1019
|
100
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |